London's High Court ruled that a second patent held by Moderna was invalid.
Pfizer and BioNTech's COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court in London, England, found in a decision released on July 2.
The patent "Is valid," the court stated, adding that it was infringed "Given that Pfizer/BioNTech conceded that it would be infringed if valid."
The court rejected arguments made by Pfizer and BioNTech, including the argument that Moderna's patent was not novel.
The District Court of the Hague in 2023 found the patent to be invalid due to lack of novelty versus the method, but the London court said it weighed other evidence and found some factors persuasive that the Hague did not.
The court also ruled that a second patent held by Moderna was invalid.
A spokesperson for Moderna said the company was pleased the court "Recognized the innovation of Moderna scientists by confirming the validity and infringement" of one of its patents.
No comments:
Post a Comment